These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1534159)

  • 1. Changes in dopamine D1 and D2 receptor binding in the substantia nigra following intrastriatal injection of a retrograde neurotoxin (volkensin).
    Black MD; Crossman AR
    Neurosci Lett; 1992 Jan; 134(2):180-2. PubMed ID: 1534159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.
    Filloux F; Dawson TM; Wamsley JK
    Brain Res Bull; 1988 Apr; 20(4):447-59. PubMed ID: 3135077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective localization of striatal D1 receptors to striatonigral neurons.
    Harrison MB; Wiley RG; Wooten GF
    Brain Res; 1990 Oct; 528(2):317-22. PubMed ID: 2148707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Exp Neurol; 1991 Mar; 111(3):282-92. PubMed ID: 1825638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons.
    Pollack AE; Harrison MB; Wooten GF; Fink JS
    Brain Res; 1993 Dec; 631(1):161-6. PubMed ID: 8298989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The time course of changes in D1 and D2 receptor binding in the striatum following a selective lesion of striatonigral neurons.
    Harrison MB; Wiley RG; Wooten GF
    Brain Res; 1992 Nov; 596(1-2):330-6. PubMed ID: 1334779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigral dopamine autoreceptors are exclusively of the D2 type: quantitative autoradiography of [125I]iodosulpride and [125I]SCH 23982 in adjacent brain sections.
    Morelli M; Mennini T; Di Chiara G
    Neuroscience; 1988 Dec; 27(3):865-70. PubMed ID: 2978051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
    Savasta M; Dubois A; Benavides J; Scatton B
    Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase.
    Hervé D; Lévi-Strauss M; Marey-Semper I; Verney C; Tassin JP; Glowinski J; Girault JA
    J Neurosci; 1993 May; 13(5):2237-48. PubMed ID: 8478697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
    Beckstead RM
    Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of suicide transport lesions of the striatonigral or striatopallidal pathways on subsets of striatal neurons.
    Roberts RC; Harrison MB; Francis SM; Wiley RG
    Exp Neurol; 1993 Dec; 124(2):242-52. PubMed ID: 7507060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
    Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 and D2 dopamine receptors in human substantia nigra: localization and the effect of aging.
    De Keyser J; De Backer JP; Vauquelin G; Ebinger G
    J Neurochem; 1991 Apr; 56(4):1130-3. PubMed ID: 1825842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography.
    Altar CA; Marien MR
    J Neurosci; 1987 Jan; 7(1):213-22. PubMed ID: 2949066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats.
    Berger K; Przedborski S; Cadet JL
    Brain Res Bull; 1991 Feb; 26(2):301-7. PubMed ID: 1826461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML; Giorgi O; Ongini E; Mele S; Biggio G
    Life Sci; 1986 Jul; 39(4):321-8. PubMed ID: 3526066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions.
    Besson MJ; Graybiel AM; Nastuk MA
    Neuroscience; 1988 Jul; 26(1):101-19. PubMed ID: 2901690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration.
    Ujike H; Akiyama K; Nishikawa H; Onoue T; Otsuki S
    Brain Res; 1991 Feb; 540(1-2):159-63. PubMed ID: 1829015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.